Opportunity
Federal Register #DEA-1362
DEA Schedules Hearing on Proposed Marijuana Rescheduling (No Procurement)
Buyer
Drug Enforcement Administration
Posted
April 28, 2026
Respond By
May 28, 2026
Identifier
DEA-1362
This notice details a regulatory hearing, not a procurement opportunity, regarding the proposed rescheduling of marijuana under the Controlled Substances Act: - Government Buyer: - Department of Justice, Drug Enforcement Administration (DEA), Diversion Control Division - Purpose: - Conduct a formal hearing on the proposed rule to transfer marijuana from Schedule I to Schedule III - Hearing will receive factual evidence and expert opinion - Hearing Details: - Scheduled from June 29 to July 15 at the DEA Hearing Facility in Arlington, VA - Recess from July 3 to July 6 - Participation notices required in advance - No products, part numbers, or purchase quantities are requested - No OEMs or commercial vendors are involved - Notable Requirements: - Hearing is mandated by Executive Order 14370 for expedited rulemaking - Open to interested parties for participation - Locations: - DEA Hearing Facility, Arlington, VA (place of performance) - DEA Headquarters, Springfield, VA (contracting office)
Description
The Drug Enforcement Administration (DEA) will hold a hearing regarding the proposed rescheduling of marijuana into schedule III of the Controlled Substances Act starting June 29, 2026. This follows a Notice of Proposed Rulemaking published on May 21, 2024, and is conducted in accordance with Executive Order 14370 to complete the process expeditiously. Interested persons must provide written notice of participation by May 28, 2026. The hearing will be held at the DEA Hearing Facility in Arlington, VA, and conclude by July 15, 2026.